Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Celsion nets $9.1mm through registered direct offering

Executive Summary

Celsion Corp. (heat-based cancer therapies) netted $9.1mm through the registered direct offering of 6.3mm common shares at $1.57 (a 38% premium to the ten-day market average). Funds affiliated with Sabby Management led the financing (5mm shares), and were joined by funds managed by Cranshire Capital (1.3mm shares). HC Wainwright was the placement agent.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
    • Liposomes
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Private Investment in Public Equity

Related Companies